A New Frontier in PTSD Treatment
A major shift just happened in U.S. mental health policy—and it directly impacts the future of PTSD treatment.
This week, President Trump signed an executive order to accelerate research and FDA review of psychedelic therapies like ibogaine, specifically targeting PTSD and veteran mental health. ([New York Post][1])
For decades, promising treatments were constrained by Schedule I barriers. That is now changing.
The new directive:
• Removes key regulatory roadblocks to research
• Encourages FDA fast-tracking of breakthrough therapies
• Expands clinical trial support across federal agencies
• Signals a broader openness to novel neuropsychiatric approaches ([The Wall Street Journal][2])
This is more than policy—it’s a paradigm shift.
At Neuritek, we have long believed that PTSD requires new mechanisms, not incremental improvements.
Our lead program, NRTK001, is being advanced for PTSD with:
• An established human safety profile
• A differentiated mechanism targeting neurobiological pathways underlying trauma
• A focus on scalable, clinically validated solutions
While psychedelics like ibogaine are showing promise in early research for PTSD and related conditions ([Houston Chronicle][3]), the field is still searching for safe, regulated, and accessible therapies that can reach millions of patients.
That’s where companies like Neuritek come in.
We see this moment as validation of a broader truth:
👉 The FDA and policymakers are now open to innovation in mental health
👉 The urgency around PTSD—especially for veterans—is finally being recognized
👉 The next generation of treatments will combine novel science with real-world scalability
We are actively advancing toward that future.
If you’re an investor, clinical partner, or collaborator interested in shaping the next era of PTSD treatment, this is a clarion call for your to join our battle to cure PTSD forever.
[1]: https://nypost.com/2026/04/18/us-news/trump-signs-order-to-fast-track-ibogaine-psychedelic-drug-research-to-treat-veterans-with-ptsd/?utm_source=chatgpt.com "Trump signs order to fast track psychedelic drug research to treat veterans with PTSD"
[2]: https://www.wsj.com/politics/policy/how-joe-rogan-convinced-trump-to-fast-track-review-of-psychedelic-drugs-3618fd73?utm_source=chatgpt.com "How Joe Rogan Convinced Trump to Fast-Track Review of Psychedelic Drugs"
[3]: https://www.houstonchronicle.com/news/houston-texas/trending/article/ibogaine-drug-research-22213632.php?utm_source=chatgpt.com "Trump eased restrictions on research for ibogaine. Here's what to know about the psychedelic drug."